VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 188 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $12,000 | -36.8% | 1,130 | -32.2% | 0.00% | – |
Q1 2022 | $19,000 | -34.5% | 1,667 | -9.4% | 0.00% | – |
Q4 2021 | $29,000 | +3.6% | 1,840 | +13.9% | 0.00% | – |
Q3 2021 | $28,000 | -17.6% | 1,616 | +1.0% | 0.00% | – |
Q2 2021 | $34,000 | +41.7% | 1,600 | 0.0% | 0.00% | – |
Q1 2021 | $24,000 | +2300.0% | 1,600 | +1423.8% | 0.00% | – |
Q4 2020 | $1,000 | – | 105 | +110.0% | 0.00% | – |
Q3 2020 | $0 | – | 50 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |